{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:42:07Z","timestamp":1790876527950,"version":"4.1.0"},"reference-count":46,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,10,22]]},"DOI":"10.1248\/bpb.b24-00472","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T22:10:58Z","timestamp":1729548658000},"page":"1699-1707","source":"Crossref","is-referenced-by-count":3,"title":["Cloperastine Reduces IL-6 Expression &lt;i&gt;via&lt;\/i&gt; Akt\/GSK3\/Nrf2 Signaling in Monocytes\/Macrophages and Ameliorates Symptoms in a Mouse Sepsis Model Induced by Lipopolysaccharide"],"prefix":"10.1248","volume":"47","author":[{"given":"Ayumi","family":"Kawamura","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sawamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunari","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3). <i>JAMA<\/i>, <b>315<\/b>, 801\u2013810 (2016).","DOI":"10.1001\/jama.2016.0287"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. <i>Crit. Care Med.<\/i>, <b>41<\/b>, 1167\u20131174 (2013).","DOI":"10.1097\/CCM.0b013e31827c09f8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cohen J, Opal S, Calandra T. Sepsis studies need new direction. <i>Lancet Infect. Dis.<\/i>, <b>12<\/b>, 503\u2013505 (2012).","DOI":"10.1016\/S1473-3099(12)70136-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Rietschel ET, Brade H. Bacterial endotoxins. <i>Sci. Am.<\/i>, <b>267<\/b>, 54\u201361 (1992).","DOI":"10.1038\/scientificamerican0892-54"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Savva A, Roger T. Targeting Toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. <i>Front. Immunol.<\/i>, <b>4<\/b>, 387 (2013).","DOI":"10.3389\/fimmu.2013.00387"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Fink MP, Warren HS. Strategies to improve drug development for sepsis. <i>Nat. Rev. Drug Discov.<\/i>, <b>13<\/b>, 741\u2013758 (2014).","DOI":"10.1038\/nrd4368"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. <i>J. Exp. Med.<\/i>, <b>169<\/b>, 333\u2013338 (1989).","DOI":"10.1084\/jem.169.1.333"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, Matsumoto H, Matsuura H, Matsubara T, Shimizu K, Ogura H, Matsuura Y, Kishimoto T. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>117<\/b>, 22351\u201322356 (2020).","DOI":"10.1073\/pnas.2010229117"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Honda S, Sato K, Totsuka N, Fujiyama S, Fujimoto M, Miyake K, Nakahashi-Oda C, Tahara-Hanaoka S, Shibuya K, Shibuya A. Marginal zone B cells exacerbate endotoxic shock <i>via<\/i> interleukin-6 secretion induced by Fc\u03b1\/\u03bcR-coupled TLR4 signalling. <i>Nat. Commun.<\/i>, <b>7<\/b>, 11498 (2016).","DOI":"10.1038\/ncomms11498"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Iura S, Ojima Y, Amakura Y, Yoshimura M, Sawamoto A, Okuyama S, Furukawa Y, Nakajima M. T-cell activation-inhibitory assay: a proposed novel method for screening caloric restriction mimetics. <i>Biomed. Res.<\/i>, <b>40<\/b>, 235\u2013241 (2019).","DOI":"10.2220\/biomedres.40.235"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ishikawa S, Sawamoto A, Okuyama S, Nakajima M. T-cell activation-inhibitory assay to screen caloric restriction mimetics drugs for drug repositioning. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 550\u2013556 (2021).","DOI":"10.1248\/bpb.b20-00889"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kadota N, Yoshida A, Sawamoto A, Okuyama S, Nakajima M. Ibudilast reduces IL-6 levels and ameliorates symptoms in lipopolysaccharide-induced sepsis mice. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 1180\u20131184 (2022).","DOI":"10.1248\/bpb.b22-00284"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Catania MA, Cuzzocrea S. Pharmacological and clinical overview of cloperastine in treatment of cough. <i>Ther. Clin. Risk Manag.<\/i>, <b>7<\/b>, 83\u201392 (2011).","DOI":"10.2147\/TCRM.S16643"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Li B, Yu Y, Jiang Y, Zhao L, Li A, Li M, Yuan B, Lu J, Dong Z, Zhao J, Liu K. Cloperastine inhibits esophageal squamous cell carcinoma proliferation <i>in vivo<\/i> and <i>in vitro<\/i> by suppressing mitochondrial oxidative phosphorylation. <i>Cell Death Discov.<\/i>, <b>7<\/b>, 166 (2021).","DOI":"10.1038\/s41420-021-00509-w"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kim SH, Lee TH, Lee SM, Park JH, Park KH, Jung M, Jung H, Mohamed MAA, Baek NI, Chung IS, Kim J. Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators <i>via<\/i> MAPK inhibition and NF-\u03baB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock. <i>Exp. Biol. Med.<\/i> (Maywood), <b>240<\/b>, 946\u2013954 (2015).","DOI":"10.1177\/1535370214558022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Lee JW, Bae CJ, Choi YJ, Kim SI, Kwon YS, Lee HJ, Kim SS, Chun W. 3,4,5-Trihydroxycinnamic acid inhibits lipopolysaccharide (LPS)-induced inflammation by Nrf2 activation <i>in vitro<\/i> and improves survival of mice in LPS-induced endotoxemia model <i>in vivo.<\/i> <i>Mol. Cell. Biochem.<\/i>, <b>390<\/b>, 143\u2013153 (2014).","DOI":"10.1007\/s11010-014-1965-y"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mussbacher M, Derler M, Bas\u00edlio J, Schmid JA. NF-\u03baB in monocytes and macrophages\u2014an inflammatory master regulator in multitalented immune cells. <i>Front. Immunol.<\/i>, <b>14<\/b>, 1134661 (2023).","DOI":"10.3389\/fimmu.2023.1134661"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hu SL, Huang CC, Tzeng TT, Liu SC, Tsai CH, Fong YC, Tang CH. S1P promotes IL-6 expression in osteoblasts through the PI3K, MEK\/ERK and NF-\u03baB signaling pathways. <i>Int. J. Med. Sci.<\/i>, <b>17<\/b>, 1207\u20131214 (2020).","DOI":"10.7150\/ijms.44612"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Winkler C, Ferdous F, Dimmick M, Scott T. Lipopolysaccharide induced interleukin-6 production is mediated through activation of ERK 1\/2, p38 MAPK, MEK, and NF\u03baB in chicken thrombocytes. <i>Dev. Comp. Immunol.<\/i>, <b>73<\/b>, 124\u2013130 (2017).","DOI":"10.1016\/j.dci.2017.03.017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. <i>Nat. Immunol.<\/i>, <b>6<\/b>, 777\u2013784 (2005).","DOI":"10.1038\/ni1221"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhang WJ, Wei H, Hagen T, Frei B. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase\/Akt signaling pathway. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>104<\/b>, 4077\u20134082 (2007).","DOI":"10.1073\/pnas.0700305104"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Guha M, Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. <i>J. Biol. Chem.<\/i>, <b>277<\/b>, 32124\u201332132 (2002).","DOI":"10.1074\/jbc.M203298200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Taguchi K, Hirano I, Itoh T, Tanaka M, Miyajima A, Suzuki A, Motohashi H, Yamamoto M. Nrf2 enhances cholangiocyte expansion in Pten-deficient livers. <i>Mol. Cell. Biol.<\/i>, <b>34<\/b>, 900\u2013913 (2014).","DOI":"10.1128\/MCB.01384-13"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K, Yamamoto M. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. <i>Nat. Commun.<\/i>, <b>7<\/b>, 11624 (2016).","DOI":"10.1038\/ncomms11624"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Guma M, Wang Y, Viollet B, Liu-Bryan R. AMPK activation by A-769662 controls IL-6 expression in inflammatory arthritis. <i>PLOS ONE<\/i>, <b>10<\/b>, e0140452 (2015).","DOI":"10.1371\/journal.pone.0140452"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Yeligar SM, Machida K, Kalra VK. Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1\u03b1 and Nrf2 to attenuate inflammatory cytokine expression. <i>J. Biol. Chem.<\/i>, <b>285<\/b>, 35359\u201335373 (2010).","DOI":"10.1074\/jbc.M110.138636"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ross D, Siegel D. The diverse functionality of NQO1 and its roles in redox control. <i>Redox Biol.<\/i>, <b>41<\/b>, 101950 (2021).","DOI":"10.1016\/j.redox.2021.101950"},{"key":"28","unstructured":"28) Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G, Vlahos CJ. Wortmannin. a potent and selective inhibitor of phosphatidylinositol-3-kinase. <i>Cancer Res.<\/i>, <b>54<\/b>, 2419\u20132423 (1994)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA. Increased plasma levels of interleukin-6 in sepsis. <i>Blood<\/i>, <b>74<\/b>, 1704\u20131710 (1989).","DOI":"10.1182\/blood.V74.5.1704.bloodjournal7451704"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. <i>Am. J. Med.<\/i>, <b>91<\/b>, 23\u201329 (1991).","DOI":"10.1016\/0002-9343(91)90069-A"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. <i>Ann. Intern. Med.<\/i>, <b>119<\/b>, 771\u2013778 (1993).","DOI":"10.7326\/0003-4819-119-8-199310150-00001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. <i>Ann. Surg.<\/i>, <b>215<\/b>, 356\u2013362 (1992).","DOI":"10.1097\/00000658-199204000-00009"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) G\u00e5rdlund B, Sj\u00f6lin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. <i>J. Infect. Dis.<\/i>, <b>172<\/b>, 296\u2013301 (1995).","DOI":"10.1093\/infdis\/172.1.296"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Higa M, Oka M, Fujihara Y, Masuda K, Yoneda Y, Kishimoto T. Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>115<\/b>, E1214\u2013E1220 (2018).","DOI":"10.1073\/pnas.1719921115"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Yaku A, Inagaki T, Asano R, <i>et al.<\/i> Regnase-1 prevents pulmonary arterial hypertension through mRNA degradation of interleukin-6 and platelet-derived growth factor in alveolar macrophages. <i>Circulation<\/i>, <b>146<\/b>, 1006\u20131022 (2022).","DOI":"10.1161\/CIRCULATIONAHA.122.059435"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ruiz-Alcaraz AJ, Mart\u00ednez-Esparza M, Ca\u00f1o R, Hern\u00e1ndez-Caselles T, Recarti C, Llanos L, Zapater P, Tapia-Abell\u00e1n A, Mart\u00edn-Orozco E, P\u00e9rez-Mateo M, Such J, Garc\u00eda-Pe\u00f1arrubia P, Franc\u00e9s R. Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion. <i>Eur. J. Clin. Invest.<\/i>, <b>41<\/b>, 8\u201315 (2011).","DOI":"10.1111\/j.1365-2362.2010.02368.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Arendt BK, Velazquez-Dones A, Tschumper RC, Howell KG, Ansell SM, Witzig TE, Jelinek DF. Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells. <i>Leukemia<\/i>, <b>16<\/b>, 2142\u20132147 (2002).","DOI":"10.1038\/sj.leu.2402714"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Xiao M, Zhu T, Zhang W, Wang T, Shen YC, Wan QF, Wen FQ. Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-\u03baB in mice. <i>Int. J. Mol. Sci.<\/i>, <b>15<\/b>, 19355\u201319368 (2014).","DOI":"10.3390\/ijms151119355"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Chao J, Wood JG, Gonzalez NC. Alveolar macrophages initiate the systemic microvascular inflammatory response to alveolar hypoxia. <i>Respir. Physiol. Neurobiol.<\/i>, <b>178<\/b>, 439\u2013448 (2011).","DOI":"10.1016\/j.resp.2011.03.008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>23<\/b>, 168\u2013175 (2003).","DOI":"10.1161\/01.ATV.0000051384.43104.FC"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Zhao J, Liu Z, Chang Z. Lipopolysaccharide induces vascular endothelial cell pyroptosis <i>via<\/i> the SP1\/RCN2\/ROS signaling pathway. <i>Eur. J. Cell Biol.<\/i>, <b>100<\/b>, 151164 (2021).","DOI":"10.1016\/j.ejcb.2021.151164"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Romano M, Viana E, Martins JD, Da Silva RC. Evaluation of congestion levels in septic patients admitted to critical care units with a combined venous excess-lung ultrasound score (VExLUS)\u2014a research protocol. <i>POCUS J.<\/i>, <b>8<\/b>, 93\u201398 (2023).","DOI":"10.24908\/pocus.v8i1.16188"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Yimin, Kohanawa M, Minagawa T. Up-regulation of granulomatous inflammation in interleukin-6 knockout mice infected with <i>Rhodococcus aurantiacus<\/i>. <i>Immunology<\/i>, <b>110<\/b>, 501\u2013506 (2003).","DOI":"10.1111\/j.1365-2567.2003.01762.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Yimin, Kohanawa M. A regulatory effect of the balance between TNF-alpha and IL-6 in the granulomatous and inflammatory response to <i>Rhodococcus aurantiacus<\/i> infection in mice. <i>J. Immunol.<\/i>, <b>177<\/b>, 642\u2013650 (2006).","DOI":"10.4049\/jimmunol.177.1.642"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. <i>J. Basic Clin. Pharm.<\/i>, <b>7<\/b>, 27\u201331 (2016).","DOI":"10.4103\/0976-0105.177703"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Ahmed SM, Luo L, Namani A, Wang XJ, Tang X. Nrf2 signaling pathway: pivotal roles in inflammation. <i>Biochim. Biophys. Acta Mol. Basis Dis.<\/i>, <b>1863<\/b>, 585\u2013597 (2017).","DOI":"10.1016\/j.bbadis.2016.11.005"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/10\/47_b24-00472\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T03:30:33Z","timestamp":1734751833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/10\/47_b24-00472\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00472","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"article-number":"b24-00472"}}